Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment
Authors:
- 1 February 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 47 (2) , 123-129
Abstract
Purpose: The aim of this study was to evaluate brain FDG PET for short- to medium-term prediction of cognitive decline, need for assisted living, and survival in acutely hospitalized geriatric patients with newly detected clinically uncertain cognitive impairment (CUCI). Materials and Methods: The study included 96 patients (62 females, 81.4 ± 5.4 years) hospitalized due to (sub)acute admission indications with newly detected CUCI (German Clinical Trials Register DRKS00005041). FDG PET was categorized as “neurodegenerative” (DEG+) or “nonneurodegenerative” (DEG−) based on visual inspection by 2 independent readers. In addition, each individual PET was tested voxel-wise against healthy controls (P < 0.001 uncorrected). The resulting total hypometabolic volume (THV) served as reader-independent measure of the spatial extent of neuronal dysfunction/degeneration. FDG PET findings at baseline were tested for association with the change in living situation and change in vital status 12 to 24 months after PET. The association with the annual change of the CDR-SB (Clinical Dementia Rating Sum of Boxes) after PET was tested in a subsample of 72 patients. Results: The mean time between PET and follow-up did not differ between DEG+ and DEG− patients (1.37 ± 0.27 vs 1.41 ± 0.27 years, P = 0.539). Annual change of CDR-SB was higher in DEG+ compared with DEG− patients (2.78 ± 2.44 vs 0.99 ± 1.81, P = 0.001), and it was positively correlated with THV (age-corrected Spearman ρ = 0.392, P = 0.001). DEG+ patients moved from at home to assisted living significantly earlier than DEG− patients (P = 0.050). Survival was not associated with DEG status or with THV. Conclusions: In acutely hospitalized geriatric patients with newly detected CUCI, the brain FDG PET can contribute to the prediction of further cognitive/functional decline and the need for assisted living within 1 to 2 years.Keywords
This publication has 27 references indexed in Scilit:
- Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent LiteratureJournal of Nuclear Medicine, 2011
- Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive ImpairmentJournal of Nuclear Medicine, 2011
- PET translates neurophysiology into images: A review to stimulate a network between neuroimaging and basic researchJournal of Cellular Physiology, 2011
- Alzheimer's Disease Neuroimaging Initiative (ADNI)Neurology, 2010
- EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2European Journal of Nuclear Medicine and Molecular Imaging, 2009
- Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s diseaseEuropean Journal of Nuclear Medicine and Molecular Imaging, 2005
- Capacity and coercion: dilemmas in the discharge of older people with dementia from general hospital settingsAge and Ageing, 2004
- Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PETMolecular Genetics and Metabolism, 2003
- Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Cognitive impairment in medical inpatients. I: Screening for dementia-is history better than mental state?Age and Ageing, 1997